0001179110-17-009169.txt : 20170616 0001179110-17-009169.hdr.sgml : 20170616 20170616093219 ACCESSION NUMBER: 0001179110-17-009169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170615 FILED AS OF DATE: 20170616 DATE AS OF CHANGE: 20170616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brownlie Keith L CENTRAL INDEX KEY: 0001518575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 17914951 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgar.xml FORM 4 - X0306 4 2017-06-15 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001518575 Brownlie Keith L C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827 1 0 0 0 Common Stock, par value $0.001 per share 2017-06-15 4 A 0 10000 A 10000 D Non-Qualified Stock Option (right to buy) 2.32 2017-06-15 4 A 0 15000 0 A 2018-06-15 2027-06-15 Common Stock 15000 15000 D Non-Qualified Stock Option (right to buy) 2.32 2017-06-15 4 A 0 8000 0 A 2018-06-15 2027-06-15 Common Stock 8000 8000 D On June 15, 2017, the Company awarded 10,000 shares of Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan subject to time-based forfeiture restrictions. Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. Such option vests in three equal annual installments beginning June 15, 2018. 100% of the total amount of shares subject to the Option vests on June 15, 2018. /s/ Avery W. Catlin, attorney-in-fact for Keith L. Brownlie 2017-06-16